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cardiotoxicity (87%), however the difference was not statistically
significant.
Conclusions: AC CMP can occur at lower cumulative doses.
Doxorubicin dose, time to development of AC CMP and grade of
cardiotoxicity did not affect the response to treatment. Large
prospective studies to explore the role of biomarkers and genetic
polymorphism in early detection and prevention of AC CMP
respectively need to be conducted.
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Aims: To study the clinical profile of Takotsubo cardiomyopathy&
DCMP.
Methods: The study was conducted on 60 patients in Deptt of
Medicine G.S.V.M. Medical college, in between January 2012 to
September 2013.
Inclusion criteria were: Modified Mayo Criteria.
 Signs & Symptoms of Heart failure
 New ECG abnormalities( ST- segment elevation or T-wave
inversion or modest elevation in cardiac troponin)
 Left ventricular ejection fraction < 45%
 Absence of obstructive coronary disease
Echo done in all cases
Results: There is a significant difference in the sex distribution
between the two types of cardiomyopathies ( p¼0.02), DCMP being
more common in males (68%) while TCM more common in fe-
males (90%).
None of the cases of TCM presented with pedal edema & pan-
systolic murmur while 66% cases of DCMP had pedal edema & all
of them had pansystolic murmur ( p < 0.001)
There is a significant association between psychological stress&
TCM (p<0.001)
There is a significant association between Alcohol & DCMP.
All TCM cases had a very good prognosis & all cases improved
significantly within 3 months
Conclusion: DCMP is more common in males(68%) while TCM is
more common in females (90%).
None of the cases of TCM presented with pedal edema & pan-
systolic murmur while cases of DCMP had pedal edema & all of
them had pansystolic murmur.
There is a significant association between psychological stress&
TCM.
There is a significant association between Alcohol & DCMP.
All TCM cases had a very good prognosis & all cases improved
significantly within 3 months with proper management and care.
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Background: Uremic cardiomyopathy is the most important
cause of death amongst end stage renal disease. The incidence
of Ischemic heart disease (IHD) in such patients is only 11%
worldwide. However, incidence of IHD is unknown in Eastern
Indian end stage renal disease patients with uremic
cardiomyopathy.
Methods: A total of 90 patients who underwent renal trans-
plantation at our institute were enrolled for the study. All un-
derwent Echocardiography as routine pre-transplant evaluation
protocol. Those with uremic cardiomyopathy underwent Dobut-
amine Stress Echocardiography (DSE) for assessment of the
presence of IHD. All such patients were also evaluated for pres-
ence or absence of standard CAD risk factors.
Results: 30 out of 90 patients (33%) were diagnosed to have Uremic
cardiomyopathy. 23 patients were male and 7 were female. 11%
were smokers, 10% hypertensives, 9% diabetics and 10% were
dyslipidemic. DSE was positive in only 5 patients (16.66%).
Conclusion: The incidence of IHD in end stage renal failure pa-
tients with Uremic Cardiomyopathy in Eastern India is higher
than the world literature.
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Background: Angiotensin converting enzyme inhibitors (ACE-I) or
angiotensin receptor blockers (ARB) and beta blockers (BB) are
class I indications in heart failure (HF) patients with an ejection
fraction (EF) <40%. Little is known about the use of these medi-
cations in outpatients with systolic HF in India.
Methods: PINNACLE® India is the first cardiovascular quality
improvement program in India to capture, report and improve
outpatient performance measure. Among patients with EF <40%
enrolled between January 2012 and June 2014from 11 outpatient
centers, we evaluated the use of ACE-I/ARB, BB or both on any
outpatient encounter.
Results: In 52880 patients with reported EF, 15940 (30%) had an EF
40%.The frequency of ACE-I/ARB; BB; and combined ACE-I/
ARB+BB use was documented in 5257 (33%); 5450 (34%); and 4647
(29%) of patients with EF40%, respectively. Women, patients >65
years and those receiving care in practices without electronic
medical records had lower documented medication use(Ta-
ble).The number of patients receiving recommended medications
increased after the first 3 months of reporting and subsequently
remained steady(data not shown).
Conclusions: Among patients with systolic HF enrolled in the
PINNACLE® India Registry, about 2/3rddid not have documen-
tation of receipt of guideline recommended medications. A
small improvement was observed in follow-up reporting. These
results indicate an opportunity to improve quality of care
concordant with treatment guidelines for patients with EF <40%
in India.
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